Areas of expertise: Venture Capital - Medicine - Impact, Matching the algorithm to the right clinical problem.
Current role: Founder & Partner, AIoTHealth, Associate, Creative Destructive Labs -CDL Rockies (Prime), CDL West (2 Health streams) & CDL Global Recovery, Research Associate Professor, University of Calgary, Senior Fellow, Fraser Institute, Editorial Board, Annals of Thoracic Surgery
Dr. Jehangir Appoo is at the intersection of Finance, Medicine and Technology as the founder of AIoTHealth, a syndicate fund investing in early stage companies applying exponential technologies to improve healthcare quality by driving personalized medicine. Jehangir combines his deep expertise at the front lines of healthcare with 2 decades of experience with hedge funds to match the algorithm with the right clinical problem. He mentors science based startup companies globally through the Creative Destruction Lab.
Jehangir’s career has been marked as a medical leader focused on innovation to drive health care improvement. After completing his Cardiac Surgery residency at the University of Alberta in 2003, Dr. Appoo completed 2 fellowships: the first in Advanced Cardiovascular surgery at the Royal Brompton Hospital, Imperial College in London, England, and the second in Thoracic Aortic Surgery, Endovascular Aortic Surgery and Heart Failure Surgery from The University of Pennsylvania. As a clinical associate professor of Cardiac surgery at U of Calgary, he helped establish the Artificial Heart Program and performed southern Alberta's first artificial heart device implant. From 2005-2019, Dr. Appoo was an active Cardiac surgeon. He founded and directed the Calgary Thoracic Aortic Program which he led to an international academic reputation.